title: Schedules of controlled substances; table of excluded nonnarcotic products: nasal decongestant inhalers manufactured by Classic Pharmaceuticals, LLC. Final rule.
abstract: Under this Final Rule, the Drug Enforcement Administration (DEA) is updating the Table of Excluded Nonnarcotic Products found in 21 CFR 1308.22 to include the Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 mg Levmetamfetamine) manufactured by Classic Pharmaceuticals, LLC and marketed under various private labels (to include the "Premier Value" and "Kroger" labels). This nonnarcotic drug product, which may be lawfully sold over the counter without a prescription under the Federal Food, Drug, and Cosmetic Act, is excluded from provisions of the Controlled Substances Act (CSA) pursuant to 21 U.S.C. 811(g)(1).
mesh_terms: D000280:Administration, Inhalation; D000662:Amphetamines / Q000145:classification*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D008694:Methamphetamine / Q000145:classification*; D014663:Nasal Decongestants / Q000145:classification*; D009330:Nebulizers and Vaporizers / Q000145:classification*; D004366:Nonprescription Drugs / Q000145:classification*; D014481:United States
chemical_list: D000662:Amphetamines; D014663:Nasal Decongestants; D004366:Nonprescription Drugs; D008694:Methamphetamine